These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 4349741)

  • 41. Influence of thyrotoxicosis on adrenergic receptors, cyclic adenosine monophosphate, glycogen and some enzymes in the heart muscle.
    Felt V; Nedvídková J; Hynie S; Mosinger B; Vavrínková H
    Czech Med; 1979; 2(1-2):11-22. PubMed ID: 230945
    [No Abstract]   [Full Text] [Related]  

  • 42. Postnatal development of glycogen- and cyclic AMP-metabolizing enzymes in mammalian skeletal muscle.
    Smith PB
    Biochim Biophys Acta; 1980 Feb; 628(1):19-25. PubMed ID: 6243998
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Augmentation of cyclic AMP content induced by lysophosphatidyl choline in rabbit hearts.
    Ahumada GG; Bergmann SR; Carlson E; Corr PB; Sobel BE
    Cardiovasc Res; 1979 Jul; 13(7):377-82. PubMed ID: 226263
    [No Abstract]   [Full Text] [Related]  

  • 44. The functions of adenosine 3':5'-cyclic monophosphate.
    Kilpatrick R; Major PW
    Biochem J; 1970 Dec; 120(4):1P-3P. PubMed ID: 4322636
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of phosphodiesterase inhibitors on heart contractile behaviour, protein kinase activity and cyclic nucleotide levels.
    Argel MI; Vittone L; Grassi AO; Chiappe LE; Chiappe GE; Cingolani HE
    J Mol Cell Cardiol; 1980 Oct; 12(10):939-54. PubMed ID: 6257913
    [No Abstract]   [Full Text] [Related]  

  • 46. The role of adenosine 3'-5'-cyclic monophosphate and catecholamines in the pigment migration process in Xenopus laevis.
    van de Veerdonk FC; Konijn TM
    Acta Endocrinol (Copenh); 1970 Jun; 64(2):364-76. PubMed ID: 4317518
    [No Abstract]   [Full Text] [Related]  

  • 47. Studies on the relationship between adenylate cyclase activity and calcium transport by cardiac sarcotubular membranes.
    Dhalla NS; Sulakhe PV; McNamara DB
    Biochim Biophys Acta; 1973 Oct; 323(2):276-84. PubMed ID: 4356542
    [No Abstract]   [Full Text] [Related]  

  • 48. Cyclic AMP in skeletal muscle.
    Mayer SE; Stull JT
    Ann N Y Acad Sci; 1971 Dec; 185():433-48. PubMed ID: 4330511
    [No Abstract]   [Full Text] [Related]  

  • 49. Cyclic 3',5'-adenosine monophosphate and bronchial tone.
    Triner L; Vulliemoz Y; Verosky M
    Eur J Pharmacol; 1977 Jan; 41(1):37-46. PubMed ID: 188660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The absence of stimulation of lipolysis by papaverine, a strong inhibitor of phosphodiesterase.
    Hynie S; Wenke M
    Eur J Pharmacol; 1975 Feb; 30(2):230-7. PubMed ID: 165081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduction by adenosine of the isoproterenol-induced increase in cyclic adenosine 3',5'-monophosphate formation and glycogen phosphorylase activity in rat heart muscle.
    Dobson JG
    Circ Res; 1978 Nov; 43(5):785-92. PubMed ID: 213204
    [No Abstract]   [Full Text] [Related]  

  • 52. Adenyl cyclase as a component of the adrenergic receptor. In: Molecular properties of drug receptors.
    Mayer SE
    Ciba Found Symp; 1970; ():43-58. PubMed ID: 4399937
    [No Abstract]   [Full Text] [Related]  

  • 53. [Progress in the research on cyclic nucleotides. I. Cyclic 3',5' adenosine monophosphate: chemical properties, metabolism and biological role].
    Hynie S; Kenerová V
    Cesk Fysiol; 1974; 23(1):1-35. PubMed ID: 4375544
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of dobutamine on rat cardiac cyclic AMP, phosphorylase a and force of contraction.
    McNeill JH
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):597-600. PubMed ID: 209506
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiac actions of glucagon.
    Lucchesi BR
    Circ Res; 1968 Jun; 22(6):777-87. PubMed ID: 4385510
    [No Abstract]   [Full Text] [Related]  

  • 56. Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3',5'-phosphate by preparations from cardiac muscle and liver.
    MURAD F; CHI YM; RALL TW; SUTHERLAND EW
    J Biol Chem; 1962 Apr; 237():1233-8. PubMed ID: 14477266
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of catecholamines, cyclic nucleotides and phosphodiesterase inhibitors on contractions of skeletal muscles in anaesthetized cats.
    Bowman WC; Nott MW
    Clin Exp Pharmacol Physiol; 1974; 1(4):309-23. PubMed ID: 4376475
    [No Abstract]   [Full Text] [Related]  

  • 58. Development of the cardiac beta adrenergic receptor in fetal rat heart.
    Martin S; Levey BA; Levey GS
    Biochem Biophys Res Commun; 1973 Oct; 54(3):949-54. PubMed ID: 4356660
    [No Abstract]   [Full Text] [Related]  

  • 59. Cyclic 3',5'-adenosine monophosphate in the human lukocyte: synthesis, degradation, andeffects n neutrophil candidacidal activity.
    Bourne HR; Lehrer RI; Cline MJ; Melmon KL
    J Clin Invest; 1971 Apr; 50(4):920-9. PubMed ID: 4323128
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of 3':5'-cyclic nucleotide phosphodiesterase in regulating tissue concentrations of adenosine 3':5'-cyclic mooophosphate.
    Davies JI
    Biochem J; 1970 Dec; 120(4):4P-5P. PubMed ID: 4322643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.